For those aiming to surpass market returns, the art of stock picking is crucial. Making wise choices in stocks can greatly enhance your overall wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
As of close of business last night, Haemonetics Corp’s stock clocked out at $93.38, up 2.17% from its previous closing price of $91.40. In other words, the price has increased by $2.17 from its previous closing price. On the day, 1.24 million shares were traded. HAE stock price reached its highest trading level at $94.985 during the session, while it also had its lowest trading level at $90.55.
Ratios:
To gain a deeper understanding of HAE’s stock, we examine its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 15.67 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 123.81. For the most recent quarter (mrq), Quick Ratio is recorded 2.09 and its Current Ratio is at 3.49. In the meantime, Its Debt-to-Equity ratio is 1.39 whereas as Long-Term Debt/Eq ratio is at 1.39.
On September 13, 2024, CL King started tracking the stock assigning a Buy rating and target price of $116.
On September 11, 2024, BofA Securities started tracking the stock assigning a Neutral rating and target price of $85.BofA Securities initiated its Neutral rating on September 11, 2024, with a $85 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Nov 11 ’24 when Lingamneni Anila bought 6,238 shares for $90.68 per share.
Strong Stewart W sold 4,312 shares of HAE for $393,039 on Jul 26 ’24. The President, Global Hospital now owns 18,196 shares after completing the transaction at $91.15 per share. On Jul 26 ’24, another insider, Strong Stewart W, who serves as the Officer of the company, bought 4,312 shares for $91.15 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, HAE now has a Market Capitalization of 4689907712 and an Enterprise Value of 5704847360. As of this moment, Haemonetics’s Price-to-Earnings (P/E) ratio for their current fiscal year is 38.78, and their Forward P/E ratio for the next fiscal year is 17.44. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 2.42. For the stock, the TTM Price-to-Sale (P/S) ratio is 3.45 while its Price-to-Book (P/B) ratio in mrq is 5.35. Its current Enterprise Value per Revenue stands at 4.191 whereas that against EBITDA is 18.159.
Stock Price History:
Over the past 52 weeks, HAE has reached a high of $97.97, while it has fallen to a 52-week low of $70.25. The 50-Day Moving Average of the stock is 21.96%, while the 200-Day Moving Average is calculated to be 14.44%.
Shares Statistics:
It appears that HAE traded 611.64K shares on average per day over the past three months and 914290 shares per day over the past ten days. A total of 50.79M shares are outstanding, with a floating share count of 49.67M. Insiders hold about 1.10% of the company’s shares, while institutions hold 115.59% stake in the company. Shares short for HAE as of 1728950400 were 5262151 with a Short Ratio of 8.44, compared to 1726185600 on 5402409. Therefore, it implies a Short% of Shares Outstanding of 5262151 and a Short% of Float of 16.08.
